OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Solent Multlple Sclerosls Theraples Llmlted Flnan¢lal Accounts for the Perlod End•d 31 Mar¢fv 2024 Company Regl8tratlon Number: 2215164

Solent Multiple Sclerosis Therapies Limited Report and Accounts for the Perlod Ended 31 March 2024 CONTENTS PAGES Report of the Directors ndependent Examinerfs Report Statement of Financial Activities Income and Exp8nditure Account Balance Sheet 54 Notes to the Accounts 7-10 The following page8 do not form part of the statutory accounts, Summary Income and Expenditure Account Income Detail 12 PhysiolOst801ReflexlShiatSU 8n8lysis 13 Bank Balances 14 Fixed Assets Detslled Income and Expendlture Account

Solent Multiple Sclerosis Therapies Llmited Accounts for the Period Ended 31 March 2024 Trustees G Woodhou8e D Revill Acting Chairman - Company Secretary PLe8 S Slroud A Alexander S Emery A Sandford E Woodhouse R Moorhead D Revill Registered Office Bradbury House 56 Hewett Road North End Portsmouth Hamp8hire P02 OQP Bankers Lloyds TSB plc 80 London Road North End Portsmouth Hampshire P02 OLX CAF Bank Limiled 25 Kings Hill Avenue Kings Hill West Mailin9 Kent ME194JG Company Number 2215154 Accountants Hunter Simmons Ltd EMP Building, Unit 1 4 Solent Road Hav8nt Hampshire P09 1JH

Solent Multiple Sclerosis Therapies Llmited Report of the Directors for the Perlod Ended 31 March 2024 Report of the Directors The directors herewith present the accounts for the period ended 31 March 2024. Actlvltles of the Company The companys principal activity is to aid the condition of those suffering from multiple sclerosis by providing guidance, practical support and therapy to those such persons. Dlrectorn The directors of the company throughout the year were as follows: PLee A Sandford S Stroud L Clarke A Alexander E Woodhouse G Woodhouse L Rickman S Emery R Moorhen D Revill R Haytèr C Alexandèr The directors do not hold any Sheres in the company. Charltable StatuB The company is a registered charlty with the Charity Commlssioners in England and Wales. Company Number and Charlty Number The company registered number is 2215154 and Ihe Registered Charity number is 299545, Govemlng Doeumant The governing document is th8 M6morandum and Articles of Association. Truste88 The directors have produced a Directors, Report as required by Company Law instead of a Trustees, Report, Raglsternd Offlce The regi&tered off ice of the charity is Bradbury House, 58 Hewett Road, North End, Portsmouth, Hampshire P02 OQP. Exomptlons Advantage has been taken in the preparation of the Director5, Report of the special exemptions applicable to small companies Conferred by Part 15 of the Companies Acl 2006. By Order of the 8oard .G Woodhou$e - Chairman Dated..l.?... rfth¥,..zo.2. It..

Independent Examiner's Report to the Trustees of Solent Multlple Sclerosis Theraples Llmited I report to the charity trustees on my examination of the accounts of the Comp8ny fcr the year ended 31 March 2024. R88ponslbllltl88 and basls of report As the trustees of the Charity (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of th8 Companies Act 2006 ('the 2006 A¢t'). Having satisfied mys&lf thal the accounts of th8 Company are not r6quir6d to be audited under Part 16 of the 2006 Act and are eligible for independ6nt 8xamination, I report in resped of my examination of your charity's accounts as carried out under section 145 of the Charities Acl 2011 ('the 2011 Act'l. In carrying out my examination I hBve followed the Directions given by the Ch8rity Commission under section 14515) (b) of the 2011 Act, Independent examlnar's 8tatem8nt I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe= eccountlng records were not kept In respect of the Company as requlred by section 386 of th8 2006 Act., or the accounts do nol accord with those records,, or the aGcounts do not comply with the accounting requirements of section 398 of the 2006 Act other than any requirement that that accounts give 8 true and fair view which is not a matter considered as part of an Independent examination,. or the accounts have not been prepared in accordance with the methixls and principles of the stat&ment of Recomménded Practic& for accounting and reporting by Charilies [applicable to charities prèparing their account8 in accordance with th8 Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)1 I have no concerns and have Come across no other matters in conneclion with the examinalion to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be r¢ached. Sèan Huntèr, FFP FIPA Inslilute of Financial Accountants Membership Number." 232174 Hunter Slmmon8 Ltd EMP Building, Unil 1 4 Solent Road Havant Hampshire P09 1JH D8te.

Solent Multlple Sclerosis Therapies Limited Statement of Flnancial Actlvlties For the Perlod Ended 31 March 2024 Not88 Mar-24 Mar-23 Gonoral Fund Incomlng R080ur¢es: Donations: Donations and Gift5 145,623 145.430 Inveslment Income Income from trading activities.. Related to objects of the ch&rity 1.650 825 Total incoming resources 147,273 146.055 Resources Expondod: DI￿¢t Charitable Expenditure Fund Raising and Publicity Management and Administration 47,676 6,801 92,931 58,597 1,574 71,431 Total reBour¢e8 expended 147,408 131,602 Net Incoming resources 11351 14,453 Balances at 31 March 2023 343,420 328,967 B8lances at 31 March 2024 343,285 343,420

Solent Multiple Sclerosis Theraples Llmlted Income and Expenditure Account For the Period Ended 31 March 2024 Mar-24 Mar-23 Totsl Income from continuing operations 147,273 146,055 Totsl expenditLtre from continuing operations 147,408 131,602 Net incomellexpendilure) for the year 135 14,453 There are no recognised gains or losses in 2024 or 2023 other than the net income for the years. The notes on pages 7 to 10 form part of the8e 8ccounts

Solent Multiple Sclerosis Therapies Limited Balance Sheet As at 31 March 2024 Not98 Mar-24 Mar-23 F5xed Assets Tangible Assets 219,115 225,564 Cuffent A88Ot8 Stocks Prepayments Cash at Bank and In Hand 374 3,375 145,829 149,204 141,805 142,179 Credltors: Amounts du• wlthln ono year Othèr creditor8 10 5,235 Not Current A880ts 143,258 136,944 Total Ngt A88ets 362,373 362,508 Fund Balance8 Income and Expenditure Account 343,285 343,420 Raserved Capit81 3,200 3,200 Operatlng Reserve Account 16,888 15,888 Total Fund Balancos 362,373 382,508 The Balance Sheet continues on the following page The notes on pages 7 to l O form part of these accounts

Solent Multlple Sclerosis Therapies Limited Balance Sheet (continued) As at 31 March 2024 Dlroctors, Statem8nt The company is entitled lo exemption from audit under Section 477 of the Companies Ad 2006 relating to small companies, for the period ended 31 March 2024. The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Acl 2006. The directors acknowledge their re8ponslbilities for., (a) ensuring that the company keeps accounting records which comply with S8Ctions 386 and 387 of th8 Companies Act 2006 and (b) preparlng flnancial statements which give a true and fair view of the state of affairs of the ¢ompany as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwi8¢ comply wlth the requirements of the Companies Act 2006 relating to financial ststements, so far as applicable to the Company. The accounts have been prepared in accordance with the sp6cial provisions of Part 15 of the Companies Act 2006 relating lo small companies and with the Financial Reporting Standard for Smaller Entities (effeclive April 2008), These accounts were approved on. 17 1lh.Y....io.2 It............. . G Woodhouse - Director R Hayter- Director The notes on pages 7 to 10 form part of these accounts

Solent Multlple Sclerosis Therapies Limited Notes to the Accounts For the Perlod Ended 31 March 2024 ACCOUNTING POLICIES Ba818 of Accountlng These aocounts have been prepared on the basis of the historical cost convention in accordance with the Financial Reporting Slandard for Smaller Entities (effective April 2008) and with applicable Accounting Standards, the Accounting and Reporting by Charilies - Statement of Recommended Practice {SORP 2005) and the Charities Act 1993. Incomlng Re80uree8 Incoming resources are reported gross. L8gacle$ and Donatlon8 Legacies and donations are accounted for when the resources are receivable or when the charitys entitlement is legally enforceable. Leg8cies received in the form of property and investments are credited at the lower of probale and market value. Other gifts in kind are included in the accounts at market value. Assets for distribution are recognised onty when distributed., assets given for use by the charity are recognised when receivable. stocks of unsold donated goods are not valued for balance sheet purposes. Grant8 R8¢elvable Grants are fecognised when recelvable, Dlrect Charltablo Expèndlturo, Fund Ralslng, Managèment and Admlnlitratlon Direct charitable expenditure comprises all expenditure directly relating to the object6 of the charity. When necessary, ¢o$ts are allocated bètween direct charitable expenditure fund-raising 8nd management and administration on the basis of apportionment of Ihe relevant expenditure. Llfo Sub8¢rlptlons There are no life subscriptions Commltment8 Commitments made by the directors that are legally binding have been accrued, Those that are not legally binding have not been charged in the accounts, but disclosed in note 11. Tanglbl8 Flx8d A8S8ts and Deprnclatlon Tangible fixed assets are stated at Gost. Depreciation is provided over the expected useful lives of each cat8gory of tangible fixed asset as follows: Furniture and Office Equ4oment 250k on net book value Plant and Equipment 25¥0 on net book value Buildings Depreciated to reflect a valuation of £35000 Improvements to Freehold Property 2Vo on cost The Compression Chamber and previous Improvements to Freehold Property are fully depreciated. Freehold Land has not been depreciated,

Solent Multlple Sclerosls Therapies Limited Notes to the Accounts For the Perlod Ended 31 March 2024 ACCOUNTING POLICIES (contlnued) Stocks Stocks are valued at the lower of Gost and net realisable value after making due allowance for any obsolete or slow-moving items. Cost incltsdes direct m£terials, labour and overheads incurred in providing ea¢h service, Net realisable value is based on estimated selling price less selling costs. Cash Flow Statement The company has tsken advantsge of the exemptlon in the Fln8ncial Reporting Standard 1 from th8 requirement lo disclose a Statement of Cash Flows on the grounds that it is a small company. INVESTMENT INCOME Mar-24 Mar-23 Bank Interest Receivab 1,850 625 MANAGEMENT AND ADMINISTRATION Mar-24 Mar-23 Central Management and Adminlstration 92,931 71,431 ANALYSIS OF TOTAL RESOURCES EXPENDED Mar-24 Mar-23 Salarie8 Utilities Supplies DepreciationlLos$ on disposal 79,546 3,441 53,369 11,052 71,431 2,778 48,447 8,946 147.408 131,602 NET INCOMING RESOURCES Mar-24 Mar-23 This is stated after charging.. DepreciationlLoss on disposal 11,052 8,946

Solent Multiple Sclerosls Therapies Limited Notes to the Accounts For the Perlod Ended 31 March 2024 INTEREST PAYABLE LESS RECEIVABLE Mar-24 Mar-23 Bank Interest Receivable 1,650 625 TAXATION No corporalion tax is payable es the company is a registered charity. TANGIBLE FIXED ASSETS Imp's to Freehold Property Com- Plant Furniture Freehold pression and and Office Property Chamber Equipment Equipment Total Cogt Brought Fomard Additions Disposals Carried Forward 254,222 39,884 22,244 74,603 6,134 397,087 4,633 4,633 4,191 9,568 6.578 392,152 5,377 69.228 254,222 39,884 Depreclatlon Brought Forward Charge for the year Eliminated on disp's Carried FoNard 75,233 5,084 4,884 22.244 63,306 2,289 5,856 171,523 1,169 8,522 7,008 3,081 173,037 22,244 62,511 Net Book Value At 31.03.24 173.905 35,000 6,715 3,495 219,115 At 31.03.23 178.989 35,000 11,297 278 225.564 The Improvements to Freehold Propety represent the costs Incurred for th8 major refurbishment of the Therapy Centre at Hewett Road, North End, Portsmouth. The works wer6 complet6d in 2008. STOCK Mar.24 Mar-23 Goods for resale 374

Solent Multiple Sclerosis Theraples Limited Notes to the Accounts For the Period Ended 31 March 2024 10 CREDITORS: AMOUNTS DUE WITHIN ONE YEAR Mar-24 Mar-23 T8xoti¢n and social security Accwals Other creditors 4,852 1,094 4,263 972 5,946 5,235 11 LIMITED LIABILiri Every member of the company undertakes to contribute to the assets of the company, in the event of the company bein9 wound up. an amount not exceeding £1. 10

Solent Multiple Sclerosis Therapies Limited Summary Income and Expenditure Account For tho Period Ended 31 March 2024 Mar-24 Mar-23 In¢omo 147,273 146.055 147,273 146,055 Expendlturn Oxygen Splints Salartes Building and Equlpment Repairs and Renewals Utilities General Office and Running Costs Insurance Premium$ Dlel Supplements,Vitamins and Goo¢Js for Resale Provision of Physio and Therapist? Fund Raising Expen8es Professional Fees HMRC Penalty Depreciation 8,207 7,704 79,546 13,195 3,441 8,931 4,294 838 11,504 5,127 1,273 71,431 12,018 2,778 6,212 4,030 75 15.561 1,574 1,273 11,052 8,946 147,408 131602 Net SurplusllDeficlt} for the Year 135 14,453 11

Solent Multiple Sclerosls Theraples Limlted Income Detall For the Perlod Ended 31 March 2024 Mar-24 Mar-23 Bank interest Book sales (Ziffit) Bonus ball Collections Community eventg Corporate grants Direcl debit donations EbayNintedlCharity Shop EPOIAPSIMasks Gift aid HDOT donation Individual donations Induction5 Masons donations 141embership National loltery grant Office bottles Physio donation Portsmouth lottery Reflex donations Solar panel payment Sponsored events Trust donatlofts 1,650 625 920 1,005 6,759 11,644 1,445 15,445 1,506 2,394 68,587 5.747 2,625 1,553 4,040 3,258 2,135 11,223 376 1,410 62,732 7,379 3,784 5,388 7,108 8,000 643 6,580 506 5,353 328 7,169 1,923 5,323 6,179 2,094 8,534 250 147 273 146 056 12

Solent Multiple Sclerosis Therapies Limited Therapy Analysis For the Period Ended 31 March 2024 Surplu81 (Deficlt) Donatlons Cost8 Physio 5,353 4,487 Osteo Refiex 7,169 5,343 1,828 12,522 9,830 2,692 13

Solent Multiple Sclerosls Therapie5 Limited Bank Analysis For the Period Ended 31 March 2024 Mar-24 Mar-23 Lloyds TSB Current account 8,378 17,385 CAF Bank account8 CAFCa8h account 22,493 11,476 Scottl8h Wldow8 Bank 1,063 1,040 Alr Rocelvor & Dolug• Tank Fund 26,884 28,098 HDOT chamber emorg•ncy rnplac6ment roser¥o 86,415 85,564 Paypal 14 242 Total Bank Balances 145,217 141,805 Cash in hand 612 Total Bank and Ca•h 145,829 141,805 Balance per accounts 145,829 141,805 14

Solent Multlple Sclerosis Therapies Llmlted Flxed Assets For the Perlod Ended 31 March 2024 Imp's to Com- Plant Furniture Freehold Freehold pression and and Office Propety Property Chamb8r Equipment Equipment Total Cost Brought Forward Additions Disposals Carrled Fo￿ard 254,222 39,884 22,244 74,603 6,134 397,087 4,633 4,633 4,191 9,568 6,576 392,152 5,377 69,226 254.222 39,884 22,244 D8pro¢latlon Brought Forward Charge for the year Eliminated on disp'8 Carried FO￿ard 75,233 5,084 4.884 22,244 63,306 2,269 3,064 62,511 5,856 171,523 1,169 8,522 3,944 7,008 3,081 173,037 80,317 22,244 Net Book Value At 31.03.24 173,905 35,000 3,495 219,115 At 31.03.23 178,989 35,000 11,297 278 225,564 15

Solent Multiple Sclerosis Therapies Llmited Detsiled Income and Expendlture Account For the Period Ended 31 March 2024 Mar-24 Mar-23 Income 147,273 146,055 147,273 146,055 Dlrnct costs Fund Raislng Costs Provision of Physio and Therapists less contribution Oxygen le88 contribution Splints EPO Payroll C08ts 5,127 1,574 11,504 11,504 15,581 8,207 8,207 7,704 838 79,646 75 71,431 105,222 42,051 96,345 49,710 Gro8• Surplu• Overhead8 Building and Equipment Repairs and Renewals Utilities Gener81 Office and Running Costs Professlonal Fees HMRC Penalty DepreciatlonlLoss on dlsposal Insurance 13,195 3,441 8,931 1,273 12,018 2,778 6,212 1,273 11,052 4,294 8,946 4.030 42,186 35,257 N•t Surplu81lD•flcltl for tha y•ar 135 14.453 Bulldlng and Equlpment Repalr8 and Renewals Repalrs and MaintenanGs Building Chamber 13,195 10,983 12,018 General Offlc• and Runnlng Co818 Staff Training Miscellaneous Telephone Postage and Slationery Computer Costs Subscriptions Bank charges Cleaning and Hygiene 522 1,728 805 132 994 480 3,472 220 314 2,603 8,931 100 229 2,696 6,212 16